Cargando…
Are We Ready to Reclassify Crohn’s Disease Using Molecular Classification?
Crohn’s disease (CD) is a type of inflammatory bowel disease. The number of IBD cases worldwide was estimated to be 4.9 million in 2019. CD exhibits heterogeneity in clinical presentation, anatomical involvement, disease behaviour, clinical course and response to treatment. The classical description...
Autores principales: | Kamal, Shahed, Parkash, Nikita, Beattie, William, Christensen, Britt, Segal, Jonathan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532006/ https://www.ncbi.nlm.nih.gov/pubmed/37762727 http://dx.doi.org/10.3390/jcm12185786 |
Ejemplares similares
-
Reclassifying stroke lesion anatomy
por: Bonkhoff, Anna K., et al.
Publicado: (2021) -
Codeine-containing medicines to be reclassified in NZ
Publicado: (2020) -
How genomics reclassifies diseases: the case of Alport syndrome
por: Torra, Roser, et al.
Publicado: (2020) -
Commentary: Descending necrotizing mediastinitis: Reclassifying a rare disease
por: Bajpai, Swara, et al.
Publicado: (2021) -
Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
por: Bowtell, DDL
Publicado: (2012)